TY - JOUR T1 - Reply: Modifying the Poor Prognosis Associated with <sup>18</sup>F-FDG–Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT) JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 969 LP - 969 DO - 10.2967/jnumed.115.158006 VL - 56 IS - 6 AU - Etienne Garin AU - Julien Edeline Y1 - 2015/06/01 UR - http://jnm.snmjournals.org/content/56/6/969.abstract N2 - ER -